Title: Higher seroproteciton rates (SPR) and higher anti-HBs concentrations in adults age 18+ achieved with 3-antigen hepatitis B vaccine (3A-HBV) compared to 1-antigen hepatitis B vaccine (1A-HBV): Results from the pivotal, double-blind, randomized Phase 3 study (PROTECT)
Title: Higher seroprotection rates (SPR) and anti-HBs titers achieved in adults with a 3-antigen hepatitis B vaccine (3A-HBV) compared to a 1-antigen hepatitis B vaccine (1A-HBV): Results of the PROTECT study
Title: High HBsAb Titers Consistent Across 3 Lots of the Tri-Antigenic Hepatitis B (HBV) Vaccine, Sci-B-Vac®: Results from the Second Pivotal Phase 3 Double-Blind, Randomized Controlled Trial Designed to Assess the Lot-to-Lot Consistency of Sci-B-Vac® in Adults (CONSTANT)
